Goldman Sachs’s Longevity Acquisition Corporation Ordinary Shares LOAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-125,000
Closed -$1.32M 5837
2020
Q3
$1.32M Hold
125,000
﹤0.01% 3875
2020
Q2
$1.33M Hold
125,000
﹤0.01% 3764
2020
Q1
$1.31M Hold
125,000
﹤0.01% 3571
2019
Q4
$1.3M Hold
125,000
﹤0.01% 3949
2019
Q3
$1.29M Hold
125,000
﹤0.01% 3860
2019
Q2
$1.26M Hold
125,000
﹤0.01% 3831
2019
Q1
$1.25M Hold
125,000
﹤0.01% 3933
2018
Q4
$1.26M Buy
+125,000
New +$1.23M ﹤0.01% 3836

Other funds holding LOAC

Goldman Sachs's LOAC Position: Q4 2020 in Review

Goldman Sachs sold out of Longevity Acquisition Corporation Ordinary Shares (LOAC) in Q4 2020, closing a stake of 125,000 shares — an estimated $1.32M sold.

Goldman Sachs first reported a position in LOAC in Q4 2018 and held it in 8 quarters. The position peaked at $1.33M in Q2 2020. 8 funds tracked by Wall St. Rank hold LOAC as of Q4 2020.

  • Goldman Sachs reported no remaining Longevity Acquisition Corporation Ordinary Shares position as of Q4 2020 after selling out during the quarter.
  • Goldman Sachs sold 125,000 Longevity Acquisition Corporation Ordinary Shares shares in Q4 2020, an estimated $1.32M.
  • Goldman Sachs first reported a position in Longevity Acquisition Corporation Ordinary Shares in Q4 2018 and held it in 8 quarters.
  • Goldman Sachs's Longevity Acquisition Corporation Ordinary Shares position peaked at $1.33M in Q2 2020.
  • 8 funds tracked by Wall St. Rank held Longevity Acquisition Corporation Ordinary Shares as of Q4 2020.

Based on Goldman Sachs's 13F filing for Q4 2020, filed 12 Feb 2021.